Why did a promising heart drug fail? Doomed drug highlights complications of meddling with cholesterol. 1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of good cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs). In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge, says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock. 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the bad low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. Youre blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway, says Kashyap. Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL, says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.
上一篇: 雅思口语回忆(网友版)
下一篇: 雅思口语试题解析(网友回忆版)
国际英语资讯:Panama says withdrawing flag from missing oil tanker in Hormuz Strait
美加州参议院通过鱼翅禁令
秋季必备:五种食物延缓皮肤衰老
调查:墨西哥人对性丑闻最宽容
国内英语资讯:Chinese, Vietnamese parties hold 15th theory seminar
如果不幸失业 你该怎么办?
旧金山禁裸体 出行须带“遮羞布”
周杰伦超话影响力破亿 这就是实力!
谁是世界上最酷的人 IT界乔布斯最牛
国内英语资讯:Military World Games unites people for a better city Wuhan
新生报到:大学生必知的六条金钱法则
体坛英语资讯:Berbatov: strikers in Man United are good enough
想创业?为什么你行我不行!
匈牙利拍香艳视频宣传人口普查
自我提升十四法:让自己做得更好
德国前总理提议建“欧洲合众国”
国际英语资讯:Assad, Putin exchange congratulations on 75th anniv. of establishing diplomatic relations
国际英语资讯:Jordan stresses role of UN in addressing regional issues
英科学家将建超大氮气球给地球降温
科学家认为每周应出去玩2小时